QL1203

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL1203, covering 2023-05-26 to 2023-05-26. Get the full timeline:

Most recent: Clinical Trial Update: QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety [Phase 3]

See pricing